News

GEN - Genetic Engineering and Biotechnology News2d
StockWatch: CGT Stocks Fall on FDA Therapeutic Products Upheaval
Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...
STAT9h
Vertex stem cell therapy spurs insulin independence
Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...
STAT5d
Top gene therapy regulator forced out at FDA
Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...
Fierce Biotech4d
Industry deeply disappointed as FDA reportedly puts cell and gene therapy chief on leave
The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...
Capricor says US FDA may not convene expert panel for co's cell therapy
Capricor Therapeutics said on Tuesday the U.S. Food and Drug Administration has indicated that an advisory panel review may ...
Pharmaceutical Technology on MSN4d
FDA cell and gene therapy director exit increases ‘volatility’ for sector
Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...
The BMJ7h
Appointment of FDA critic Vinay Prasad to senior role in agency prompts departures
Vinay Prasad—the controversial head of vaccine regulation at the US Food and Drug Administration (FDA)—has been named FDA chief medical and scientific officer.1 Traditionally separate roles, his new ...
BioSpace20h
Acting CDER Head Becomes Latest in String of FDA Leaders to Leave Agency
Curay, who stepped into the role as the agency’s top drug regulator in January, is departing in July, according to an email ...
The Pharma Letter1d
Industry anger at FDA oustings
The Alliance for Regeneration Medicine (ARM), a trade group that represents more than 400 members companies across 25 ...
RealClearMarkets22hOpinion
Medical Breakthroughs Will Be Few Without a Fast-Moving FDA
When Americans imagine the future, it always has a lot to do with flying cars, robot housekeepers, and just about anything ...
Fierce Pharma1d
FDA's acting CDER head Jacqueline Corrigan-Curay heads for the exit amid period of heavy turnover: reports
In the wake of Marks' exit, FDA commissioner Marty Makary, M.D., named Vinay Prasad, M.D., to head up CBER. In addition to that title, Prasad recently added the title of "chief medical and science ...